| 发明名称 |
COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY |
| 摘要 |
Pharmaceutical compositions for the treatment of cancer are provided. In one embodiment the composition comprises Gamitrinib and a MAPK inhibitor selected from the MAPK inhibitor is selected from RAF265, AZD6244, PLX4720, PD0325901, LGX818, MEK162, vemurafenib, trametinib and dabrafenib. Methods of treating cancer are also provided. |
| 申请公布号 |
WO2017024207(A1) |
申请公布日期 |
2017.02.09 |
| 申请号 |
WO2016US45721 |
申请日期 |
2016.08.05 |
| 申请人 |
THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY |
发明人 |
ZHANG, Gao;LIU, Qin;ALTIERI, Dario, Carlo;HERLYN, Meenhard |
| 分类号 |
A61K39/00;A61K39/395;C07K16/00;C07K16/18;C07K16/40 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
